Serum orexin-A (OXA) level decreases in polycystic ovarian syndrome

Gynecological Endocrinology

Volumn 29, Issue 4, 2013, Pages 388-390

  Yilmaz, Ercan ^a   Celik, Onder ^a   Celik, Nilufer ^b   Simsek, Yavuz ^a   Celik, Ebru ^a   Yildirim, Engin ^a  

^a INONU UNIVERSITY   (Turkey)

^b MALATYA STATE HOSPITAL   (Turkey)

Author keywords

Glucose; Insulin resistance; Metabolic disorders; OXA; PCOS

Indexed keywords

CHOLESTEROL; ESTRADIOL; FOLLITROPIN; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; LUTEINIZING HORMONE; OREXIN A; PRASTERONE SULFATE; TESTOSTERONE; TRIACYLGLYCEROL; ANDROSTENEDIONE; NEUROPEPTIDE; OREXINS; SEX HORMONE BINDING GLOBULIN; SIGNAL PEPTIDE;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; ENZYME IMMUNOASSAY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; FOLLITROPIN BLOOD LEVEL; HIP CIRCUMFERENCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; VENOUS BLOOD; WAIST CIRCUMFERENCE; ADOLESCENT; BLOOD; METABOLISM; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; ANDROSTENEDIONE; CROSS-SECTIONAL STUDIES; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUTEINIZING HORMONE; NEUROPEPTIDES; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 84883162140     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2012.754874     Document Type: Article

References (15)

1. Asunción M, Calvo RM, San Millán JL, et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000;85:2434-8.
2. Fauser B, Tarlatzis B, Chang J, et al. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003. Consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reprod 2004;19:41-7.
3. Teede HJ, Hutchison S, Zoungas S, Meyer C. Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS. Endocrine 2006;30:45-53.
4. Trakakis E, Basios G, Peppa M, et al. The prevalence of glucose metabolism abnormalities in Greek women with polycystic ovary syndrome. Gynecol Endocrine 2012;28:867-70.
5. Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein coupled receptors that regulate feeding behavior. Cell 1998;92:573-85.
6. Dalal MA, Schuld A, Haack M., et al. Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients. Neurology 2001;56:1749-51.
7. Ouedraogo R, Naslund E, Kirchgessner AL. Glucose regulates the release of orexin-A from the endocrine pancreas. Diabetes 2003;52:111-17.
8. Skrzypski M, Le TT, Kaczmarek P, et al. Orexin A stimulates glucose uptake, lipid accumulation and adiponectin secretion from 3T3-L1 adipocytes and isolated primary rat adipocytes. Diabetologia 2011;54:1841-52.
9. Tsuneki H, Murata S, Anzawa Y, et al. Age-related insulin resistance in hypothalamus and peripheral tissues of orexin knockout mice. Diabetologia 2008;4:657-67.
10. Celik O, Celik N, Hascalik S, et al. An appraisal of serum preptin levels in PCOS. Fertil Steril 2011;95:314-16.
11. Celik O, Sahin I, Celik N, et al. Diagnostic potential of serum N-terminal pro-B-type brain natriuretic peptide level in detection of cardiac wall stress in women with polycystic ovary syndrome: a cross-sectional comparison study. Hum Reprod 2007;22:2992-8.
12. Cussons AJ, Stuckey BG, Watts GF. Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives. Atherosclerosis 2006;185:227-39.
13. Tsuneki H, Wada T, Sasaoka T. Role of orexin in the regulation of glucose homeostasis. Acta Physiol 2010;198:335-48.
14. Talbott E, Clerici A, Berga SL, et al. Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study. J Clin Epidemiol 1998;51:415-22.
15. Wu FC, von Eckardstein A. Androgens and coronary artery disease. Endocr Rev 2003;24:183-217.